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ABSTRACT
Mutants of Escherichia coli, which are blocked in excision repair
(uvrA6, uvrB5, or uvrC34) are exceptionally sensitive to the antitumor drug
cTs-Pt(IT)TNH3)2ClT (cis-DDP) but not to the trans isomer. Plasmid DNA,
damaged by either the Cis or trans compound and treated with the UVRABC
excision nuclease was cu as shown by conversion of supercoiled DNA to
relaxed forms. All three protein products of the uvrA, uvrB, and uvrC genes
were required for incision. End-labeled fragments amagedwith cis-DDP and
reacted with the UVRABC nuclease were cut at the 8th phosphodiester bond 5'
and at the 4th phosphodiester bond 3' to adjacent GG's. DNA treated with
trans-DDP was not cut appreciably at adjacent GG's by the repair enzyme as
subsequent analysis of reaction products after enzyme digestion gave a
pattern similar to those obtained with control untreated fragments. The
results indicate that the UVRABC nuclease may promote cell survival by the
removal of adjacent GG's which are crosslinked by cis-Pt(II)(NH3)2C12.
INTRODUCTION
The compound cis-Pt(II)(NH3)2C12 (cis-DDP) is an effective antitumor
agent while the isomeric trans-DDP is not (1). Additionally, other platinum
compounds have been tested for antitumor efficacy and it appears that the
cis configuration is essential for these activities (2). The mechanism by
which cis-DDP and other anticancer drugs are exceptionally lethal for
neoplastic cells is unknown but it could be due to various types of DNA
repair deficiencies in cancer cells or the fact that escape from normal
regulatory control causes the replication machinery of such cells to be
particularly vulnerable to certain types of DNA damage. Inhibition of DNA
synthesis by cis-DDP has been reported in human amnion AV3 cells (3).
Additionally, the cis compound is a more potent mutagen (4-8) than the trans
isomer and induces filamentous growth in treated cells of E. coli (9,10).
Both of these phenomena may be associated with the induction of SOS DNA
repair by cis-DDP.
In conjunction with these effects, both cis-DDP and trans-DDP have been
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shown to bind to DNA and to cause a variety of monofunctional adducts plus
protein-DNA crosslinks and both inter- and intrastrand crosslinks in DNA
(2,11). The specific lesion responsible for the effects of platinum drugs
on biological systems is unknown, but it does not appear to be interstrand
crosslinks (2,11). Stone et al., (12) have proposed that both compounds act
preferentially with guanines but that only cis-DDP is stereochemically able
to form intrastrand crosslinks between adjacent guanines. Thus, an
intrastrand crosslink unique to the cis configuration may be the
biologically important lesion (12-13). This hypothesis is supported by the
data of Tullius and Lippard (14) and Royer-Pokora et al. (15). They
observed that end-labeled fragments of known base sequence were digested
differently at the position of adjacent guanines with exonuclease III when
DNA was treated with the cis compound as compared to the trans compound.
Further substantiation of DNA as the target of cis-DDP action is the
fact that strains of bacteria deficient in DNA repair are less able to
survive exposure as measured by colony forming ability than wild-type cells
(9,10). Our results confirm that proficiency in excision repair is
requisite for survival in the presence of cis-DDP but not the trans isomer.
Purified proteins coded by the uvr genes were used to reconstitute the
UVRABC nuclease to study the first step in excision repair which is the
incision reaction at lesions in DNA (16). Damage in plasmid DNA caused by
either cis or trans-DDP was substrate for the UVRABC nuclease which cut
plasmid DNA treated with either compound. Adducts caused by these compounds
in end-labeled linear DNA were recognized differently by the nuclease as
predominant incisions were detected at the 8th phosphodiester bond to the 5'
and at the 4th phosphodiester bond to the 3' of adjacent GG's for cis-DDP
while a specific cutting pattern by the UVRABC nuclease was not detected
with DNA damaged by the trans-isomer.
MATERIALS AND METHODS
Bacteria and Plasmids
The E. coli K12 strains AB1157 (uvr+), AB1886 (uvrA6), AB1885 (uvrB5)
and AB1884 (uvrC34) were obtained from Barbara Bachmann (E. coli Genetic
Stock Center at Yale University). Plasmid pBEU47 was generously supplied by
John Clark (Univ. of Calif., Berkeley) and it contained a cloned allele of
the recA gene (lexB30). This was a runaway replication plasmid and was
amplified as described by Uhlin et al. (17). Plasmids pXF3 and pBR322 were





Luria Broth (19) was used in cultivation of bacteria and in survival
experiments. Solid media contained 1.5% agar.
Survival Assays
Bacteria were grown and treated with platinum compounds as described
previously (4). The platinum compounds (250-500 ug/ml in 0.85% NaCl) were
added to logarithmically growing cells at an A550 = 0.2. At various times
after compound addition, the bacteria were suitably diluted with sterile
0.85% NaCl and plated.
Chemicals
Platinum compounds were supplied by Dr. B. Rosenberg. Restriction
enzymes, polynucleotide kinase, Klenow fragment, bacterial alkaline
phosphatase, and chemicals for electrophoresis were obtained from Bethesda
Research Labs. EY-32P]ATP (>7000 Ci/mmol) used for 5' labeling and
[a-32P]ATP (2903 mCi/mM) for 3' end labeling were obtained from ICN and NEN,
respectively.
End-Labeled Fragments
The Eco RI - Bam HI 1.8 kb DNA fragment containing the regulatory
region and 826 bases of the lexB30 gene was purified from plasmid pBEU47
according to the methods published by Sancar and Rupp (20-21). This
fragment was digested with Hinf I. Also, plasmid DNA of pXF3 was linearized
with Bam HI. These DNA molecules were end-labeled with 32P at the 5' end or
at the 3' end as described by Maniatis et al. (18). Fragments were digested
further with restriction enzymes and specific fragments purified from 6%
polyacrylamide gels. Fragments obtained from pBEU47 were Taq I - Eco RI
(105 bp) fragment and Taq I - Hinf I (189 bp) fragment consisting of bases
531-825 of the recA allele. Fragments from pXF3 were the Bam HI - Sal I
(275 bp) and Bam HI - Eco RI (377 bp) fragments consisting of bases 0 - 650
from the gene coding for tetracycline resistance. End-labeled fragments
were sequenced according to the method of Maxam and Gilbert (22).
Restriction assays followed the manufacturer's protocols.
Treatment of DNA with Platinum Drugs
Fragments of DNA (10-50 ng) end-labeled with 32p were suspended in TEN
7.4 (10 mM tris-base, lmM EDTA, 10 mM NaCl, pH 7.4). Platinum compounds
were added to yield a final concentration of 0 to 50 ig/ml in a volume of 50
pl in an Eppendorf tube and the mixture incubated at 370C for 1 or 2 hr.
The reaction was stopped by the addition of 0.1 volume of 5 M NaCl.
Platinum compounds were immediately removed by spot dialysis (23) on a VM
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millipore filter (0.05 pm pore size) which was floated on the surface of 50
ml TEN 7.4 in a petri dish with stirring at 40C for 1 hr. This procedure
has been shown to remove greater than 95% of the unbound platinum and
results in high recovery of DNA (24). The DNA was precipitated with
ethanol, dried, and suspended in the buffer used in the UVRABC nuclease
assay (16).
Plasmid DNA of pBR322 or pXF3 (0.15-0.3 ug/ul) was treated as DNA
fragments with platinum isomers. However, in the case of pBR322, only spot
dialysis was used to remove DDP.
UVRABC Excision Nuclease Reactions
Purification of the UVR proteins, reconstitution of the UVRABC excision
nuclease, and enzyme reactions were as previously described by Sancar and
Rupp (16) except for the following modifications. DNA fragments were
digested for 1 hr at 370C with purified reconstituted UVR nuclease in a
volume of 25 pl. To release platinum adducts from the DNA fragments and to
reverse protein-DNA crosslinks, an equal volume of 2 M thiourea was added
after the enzyme reaction period and incubation was continued at 500C for 2
hr (25). Carrier DNA (1 ug calf thymus DNA) was added and radioactive DNA
was purified by two extractions with phenol, an extraction with ether, and
precipitation with ethanol. Dried DNA fragments were suspended in loading
buffer, denatured by heating 90 sec at 90°C, and subjected to
electrophoresis on denaturing 8% polyacrylamide gels and/or buffer gradient
6% polyacrylamide gels (26).
For the UVR nuclease reactions with plasmid DNA, the reaction mixture
was as described by Sancar and Rupp (16) and contained 100 mM KCl.
Digestion with the UVRABC nuclease was for 30 min and reaction products were
analyzed by subjecting them to electrophoresis on 0.7% agarose gels.
Determination of Platinum Bound to DNA
The amount of platinum bound to DNA was determined by atomic absorption
spectrophotometry. A Perkin-Elmer Model 603, Series X07, atomic absorption
spectrophotometer with graphite furnace was used.
RESULTS
Effects of platinum compounds on excision repair-deficient mutants
cis-DDP but not the trans isomer is lethal to mutants of E. coli
blocked in excision repair (Fig. 1). This sensitivity was noted by the fact
that survival (colony-forming units) was reduced to 37% when uvrA, uvrB or
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Fig. 1. Survival (colony-forming ability) of Escherichia coli strains
AB1157 uvr+ (A ) AB1886 uvrA6 ( * ), AB1885 uvrB5 (U ), and AB1884 uvrC34
(A ) fr different times of exposure to (a) cis-DDP (30 pg/ml) and (bT
trans-DDP (60 pg/ml). Drugs were added to logarithmically growing cells at
A550 = 0.20.
whereas wild-type cells were not killed after 3 hr exposure. In experiments
with wild-type cells, colony-forming units doubled 1 hr after drug addition
and then remained at a plateau level for the next 2 hr. As has been
published previously (9,10), both mutant and wild-type bacteria were
inhibited in cell division by cis-DDP and formed filamentous cells (observed
microscopically). Filamentous growth of E. coli is thought to be due to the
induction of SOS repair after DNA damage by the platinum drug. One result
of the induction of SOS repair is increased cellular levels of certain DNA
repair enzymes such as the uvr gene products which function in excision
repair (27).
In contrast to the toxicity noted with cis-DDP, a higher concentration
of 60 pg trans-DDP per ml medium caused only a 30% reduction in the number
of colony-forming units of uvr mutants after 1 hr; thereafter, the number of
colony-forming units increased. Wild-type cells grew slightly better than
mutants in the presence of the trans-isomer as indicated by their higher
rate of increase in colony-forming units. Filamentation of wild-type
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Table 1. Effect of platinum drugs on cell division and turbidity of Escherichia coli.a
cis-DDP (30 ,g/ml) trans-DDP (60 ig/ml)
Absorbance550 a Filamentationb Absorbance550 a Filamentationb
Strain 90 min 180 min 180 min 90 min 180 min 180 min
AB1157 uvr+ 0.68 1.0 ++ 0.41 0.78
AB1886 uvrA6 0.74 1.0 ++ 0.45 0.75 +
AB1885 uvrB5 0.76 1.0 4+ 0.44 0.79 +
AB1884 uvrC34 0.68 0.98 ++ 0.35 0.70 +
a Platinum drug was added to logarithmically growing bacteria at A550 = 0.20. Samples were
taken periodically and A550 determined using a Bausch and Lomb Spectronic 20.
b DDP-induced filamentation at 3 hrs: (++), filaments approximately 5 times longer than
control cells; (±), approximately half of the population slightly elongated; and (-),
cells equal in size to control cells.
bacteria did not occur but uvr mutants appeared elongated during the period
1-2 hr after the addition of trans-DDP. Turbidity measurements (Table 1)
indicated that mass was increasing in all cultures in the presence of both
isomers. Since these treatments utilized concentrations of the trans
derivative twice that of the cis compound, there were resultant decreased
rates of increases in cell mass.
Cutting of damaged DNA by the UVR nuclease
Atomic absorption spectrophotometry was used to determine the amount of
platinum bound to plasmid DNA. Under the conditions of treatment, trans-DDP
Table 2. Mole ratio of cis or trans DDP bound per base pair of pBR322 DNA.
DDP Treatment Concentration rbb
( g/ml) cis trans
1 0.30 ± 0.05 1.3 ± 0.1
5 1.0 ± 0.4 3.4 ± 0.1
10 1.7 ±0.2 4.8 ±0.1
25 3.7 ± 0.2 7.9 ± 0.1
50 7.3 ± 0.1 12.8 ± 0.3
a Values determined using MS on 10 pl samples of DNA treated with cis or
trans DDP at 370C for 1 hr after removal of unbound platinum. Values are
the mean of 4 samples and their standard deviation.
b rb = mmoles DDP/moles of base pair. Moles of DDP in 10 pl samples of DNA
treated with cis or trans DDP determined by extrapolating MS Absorbance
reading from a standard plot of Absorbance (X= 266 nm) vs. Pt
concentration for H2PtCL6 standards. Concentration of DNA before
treatment was measured spectrophotometrically at an Absorbance of 260 nm
and after treatment on agarose gels stained with ethidium bromide in





Fig. 2. Agarose gel of pBR322 DNA treated with diamminedichloroplatinum(II)
before and after reaction with UVRABC nuclease. Control DNA and DNA that
was reacted with the UVRABC nuclease are shown in adjacent lanes. Drug con-
centrations used to treat DNA are shown above adjacent lanes containing the
DNA; (-) indicates lack of digestion and (+) indicates that the DNA was
digested by the UVRABC nuclease.
appeared to react more readily with pBR322 DNA than did the cis-derivative
(Table 2); there were greater mole ratios of platinum bound per mole base
pair (rb values) for equal treatment mole ratios of input platinum atoms
per DNA base pair. From these determinations, the number of platinum
adducts per pBR322 DNA molecule ranged from 1 to 30 for cis-DDP treatment
and from 5 to 60 with trans-DDP.
The platinum adducts were substrates for the UVRABC nuclease as shown
by the fact that supercoiled DNA treated with either cis- or trans-DDP was
almost totally converted to the relaxed form upon digestion with the
reconstituted enzyme (Fig. 2). All 3 protein products of the uvrA, uvrB,
and uvrC genes were needed to cut pXF3 DNA damaged with 10 ug cis-DDP/ml
(Fig. 3). When any one of the proteins were omitted, there was only a small
amount of conversion of supercoiled DNA to relaxed form, probably as a
result of a low level contamination of the subunit preparations with a
non-specific endonuclease or topoisomerase 1.
When pBR322 (data not shown) or pXF3 was reacted with DDP and the
unbound platinum compound removed by dialysis and alcohol precipitation, a
small fraction of the plasmid molecules migrated more slowly on 1% agarose
gels than monomeric forms (Fig. 4A-B). In pXF3 DNA, there were 4 visible
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Fig. 3. Agarose gel of pXF3 DNA treated with 10 pg/ml diamminedichloro-
platinum(II) and reacted with the purified UVR proteins which are indicated
above each lane.
bands which were not present on gels of untreated DNA and which were slower
migrating compared to supercoiled and relaxed monomers. Reversal of the
platinum crosslinks from DDP treated plasmids with thiourea caused a
concomitant loss of the slow migrating forms, as the DNA when subjected to
electrophoresis on agarose gels was composed of only form I and form II
monomers (Fig. 4A). The arrows in Fig. 4A-C identify the positions on
agarose gels of one such slow migrating form which migrated just above the
relaxed monomer and which was converted by thiourea treatment to molecules
having the electrophoretic mobility characteristic of supercoiled monomers.
All four of the slow migrating forms appear to be made up of combinations of
relaxed and supercoiled monomers. This is shown in Fig. 4C which is a gel
of resolved trans-DDP treated plasmids which has been incubated in 1 M
thiourea to reverse platinum crosslinks and then the DNA subjected to
electrophoresis in a second direction. Perhaps these molecules were
polymeric molecules which resulted upon ethanol precipitation of DNA
molecules containing monofunctional adducts. A second bifunctional reaction
could result in interhelical crosslinks between monomeric forms. DNA
containing adducts caused by cis-DDP gave similar results as that obtained
for trans-DDP (data not shown).
Reactions of DDP-treated pXF3 preparations with the UVRABC nuclease
resulted in the appearance of two bands of incised molecules which were
visualized on agarose gels, the monomeric form II pXF3 and one higher
molecular weight form migrating at about the position of the undigested
slowest migrating molecules (Fig. 5). Cutting by the repair enzyme occurred
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Fig. 4. Agarose gels of pXF3 DNA treated with diamminedichloro-
platinum(II) before and after reversal of platinum crosslinks with
thiourea. Lanes of gel A contain (5) control DNA without DDP
treatment, (4) DNA treated with 10 ug/ml cis-DDP for 1 hr, (3) DNA
treated with cis-DDP and the platinum cro6sTinks reversed by
incubation inFM thiourea for 3 hr at 500C, (2) DNA treated with
10 ug/ml trans-DDP for 1 hr, (1) DNA treated with trans-DDP and then
the platinum crosslinks reversed by reaction with Thihourea. (B) DNA
treated with trans-DDP was subjected to electrophoresis and then the
gel was turnedW90degrees and the plasmid molecules subjected to
electrophoresis in this second direction. (C) DNA is treated as in B
but with the exception that the gel was incubated for 16 hr in
electrophoresis buffer containing 1 M thiourea at 370C before
subjecting the DNA to electrophoresis in the second direction. The
arrow points to the position of one form of platinated DNA migrating
slightly slower than relaxed monomers of pXF3.
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Fig. 5. Agarose gel of pXF3 DNA treated with diamminedichloroplatinum(II)
before and after reaction with the UVRABC nuclease. Control DNA and DNA
that was reacted with the UVRABC nuclease are shown in adjacent lanes. Drug
concentrations used to treat DNA are shown above adjacent lanes containing
the DNA; (-) indicates lack of digestion and (+) indicates that the DNA was
digested by the UVRABC nuclease.
when plasmids were treated with concentrations ranging from 1 to 50 ig
DDP/ml. In some digests of pXF3, a greater fraction of the supercoiled
molecules treated with the cis-isomer appeared converted to the relaxed form
II molecule than with the trans-isomer.
DNA fragments end-labeled with 32p were treated with platinum
compounds and then digested by the UVRABC nuclease. Reaction products were
analyzed to determine base sequences at sites of incision. A positive
control for UVR nuclease activity was DNA damaged by UV.
Reaction products were analyzed on DNA sequencing gels and
autoradiograms are shown in Figures 6-8. Lanes containing Maxam-Gilbert
reactions (22) are labeled with the specific bases cut. The Taq I - Eco RI
DNA fragment is rich in pyrimidines and thus after UV irradiation is cut at
many sites by the repair nuclease (Fig. 6, lane 5). Incision sites were at
the 8th phosphodiester bond to the 5' side of pyrimidine dimers as published
previously (16). The DNA sequence is given to the right of the
autoradiogram. In this DNA fragment, there was one run of 3 G's located in
the middle of the fragment which was visualized on the gel. Two intense
bands were observed on gels of DNA treated with 10 jg or 50 pg cis-DDP per
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Fig. 6. Cutting of (Taq I - Eco RI)105 DNA fragments, from pBEU47 by
the UVRABC nuclease. The fragment was labeled at the 5' end. Lanes
containing Maxam-Gilbert reactions are lettered according to the bases
modified and specifically cut for each reaction. Undamaged DNA (lane 6),
DNA treated with 1 l&g/ml cis-DDP (lane 1), 10 1g/ml cis-DDP (lane 4),
50 uig/ml cis-DDP (lane 3)775 ig/ml trans-DDP (lane TFand 100 J/M2 UV (lane
5) was reacted with the repair nuclease. Reaction products were submitted
to electrophoresis on an 8% polyacrylamide denaturing gel.
3 G's and did not occur in undamaged control DNA (lane 6), in DNA damaged
with UV (lane 5), nor in DNA treated with 25 pg/ml trans-DDP (lane 2). Less
intense bands at other sites were also apparent in lane 4. These bands were
visualized due to overexposure of the film and when the film was properly
exposed only two bands were visible as in lane 3.
The Bam HI - Sal 1 (275 bp) fragment had 17 sites in its base sequence
which consisted of adjacent GG's. Fragments treated with 10 ig/ml cis-DDP
for 2 hr and reacted with the UVRABC nuclease were cut at the eighth
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Fig. 7. Reaction products obtained by digestion of DDP-damaged (Bam HI -
Sal I)275 DNA fragments with the UVRABC nuclease. The DNA fragments were



































































trans-DDP for 1 hr (lane 1), 10 ig/ml trans-DDP for 2 hr (lane 2) and
10 pg/ml cis-DDP for 2 hr (lane 3) were digested with the UVRABC nuclease
and the reaction products submitted to electrophoresis on a buffer gradient
polyacrylamide gel. Lanes containing Maxam Gilbert reactions are labeled
with the base(s) specifically cut. Bars indicate sites of incisions which
appeared more intense in DDP-treated fragments than in untreated control
DNA.
lane 3). The DNA sequence is given to the right of the autoradiogram which
shows the reaction products after being subjected to electrophoresis. Bands
due to incision reaction which occurred in treated DNA but not in control
untreated DNA are indicated by bars to the left of lane 3. The seventh bar
from the top of the autoradiogram designates a band 7 bases 5' to an AG
sequence, while the other incision sites are 7 bases 5' to GG sequences.
Less intense cutting bands were observed within and at the 5' and 3' side of
the GAGCG sequence at position 493 in pXF3 (18). No specific cutting
pattern different from control untreated DNA (lane 4) was observed in DNA
t-reated with 10 pg/ml trans-DDP for 1 or 2 hrs (lanes 1 and 2 respectively).
Similar results to these were obtained with the Taq I - Hinf 1 fragment
which contains 7 sites with adjacent GG's. Reaction products of DNA treated
with 10 pig/ml cis-DDP for 1 h gave bands on gels indicating cuts at the 5'
of each GG (data not shown).
To study incision reactions of the nuclease at the 3' side of platinum
adducts, excision assays were done on the Bam HI - Sal I DNA fragments
labeled at the 3' end and treated with 10 pg/ml DDP for 2 hr (Fig. 8).
Incisions were observed at the 4th phosphodiester bond to the 3' side of all
adjacent GG's for DNA treated with cis-DDP but not for DNA treated with the
trans isomer. No predominant cutting bands were observed 3' to AG or GXG
sequences which were also in the region visualized on gels.
DISCUSSION
cis-DDP but not trans-DDP is a potent anticancer agent which induces
filamentous growth of E. coli (9,10). The number of colony forming units
increased when bacteria were grown in broth containing trans-DDP indicating
that bacteria were able to undergo cell division in the presence of
trans-DDP. In contrast, cis-DDP caused inhibition of cell division due to
its ability to induce SOS DNA repair and colony forming units did not
increase as cells became elongated.
Survival experiments of bacteria in broth containing DDP showed that





















































Fig. 8. Reaction products obtained by digestion of DDP-damaged (Bam
HI - Sal I)275 DNA fragments with the UVRABC nuclease. The DNA
fragments were labeled at the 3' end. DNA treated with 0 DDP (lane 2)
and 10 pg/ml cis-DDP for 2 hr (lane 1) were digested with the UVRABC
nuclease and the reaction products submitted to electrophoresis on a
buffer gradient polyacrylamide gel. Lanes containing Maxam Gilbert
reactions are labeled with the base(s) specifically cut.
only the cis isomer. This was evident by the fact that bacteria blocked in
excision repair (uvrA, uvrB, or uvrC mutants) were all exceptionally
sensitive to cis-DDP. These mutants did, however, exhibit sensitivity to
trans-DDP when compared to wild-type cells with respect to rates of
increases in colony forming units. Possibly trans-DDP has other biological
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targets in addition to those of the cis-compound or causes damage in DNA
which is repaired by other pathways in addition to those involving the
UVRABC nuclease.
The uvr mutants are blocked at the first step of the excision repair
pathway that functions in the recognition and repair of a variety of lesions
such as psoralen crosslinked DNA, alkylated DNA and UV-induced pyrimidine
dimers (16). A complex reaction for the first step of the excision repair
pathways is indicated by the fact that in E. coli at least three proteins,
the gene products of uvrA, uvrB and uvrC loci, are requisite for function in
damage recognition and incision. A similar complexity is seen in
eucaryotes. Human patients with the disease xeroderma pigmentosum are
believed to be deficient in excision repair. Similar to uvr mutants of E.
coli, cell lines of xeroderma patients have been shown to be comprised of
different complementation groups and to be sensitive to UV and various
alkylating agents. Accordingly, Fraval et al. (28) reported that xeroderma
pigmentosum XP 12 BE cells were 4 times less efficient than normal cells in
surviving a given amount of cis-DDP bound to DNA.
Purified uvr gene products were used to reconstitute the UVRABC
nuclease for study of its incision activity on DNA treated with DDP. Only
the cis compound produced adducts in linear end-labeled DNA which were
detected by incision reactions of the UVR nuclease at specific base
sequences. However, supercoiled DNA treated with either compound was
sensitive to the UVRABC nuclease. Sites of enzyme incision on end-labeled
DNA fragments were determined by analysis of the reaction products on
polyacrylamide gels in comparison with fragments cut at specific bases by
the methods of Maxam and Gilbert (22). When fragments were treated with
trans-DDP we did not detect cuts at specific sites by the repair enzyme as
the reaction products resembled those of control untreated fragments after
digestion. For DNA treated with cis-DDP, the predominant sites of incision
were at the 8th phosphodiester bond 5' and at the 4th phosphodiester bond 3'
to adjacent GG's. These results indicate that only cis-DDP causes adducts
in DNA at runs of GG's which are readily detected by incision reactions of
the UVR nuclease. These platinum crosslinked guanines appear to be excised
by the UVR nuclease in a manner similar to that observed for pyrimidine
dimers in UV-irradiated DNA.
Other platinum adducts may be acted upon by the UVR nuclease but occur
less frequently than intrastrand crosslinks at adjacent GG's. Eastman (29),
for example, has detected a number of different adducts in DNA treated with
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cis-DDP. Such adducts may have been responsible for bands on
audiogradiograms which were visualized only by overexposure of the film
(Fig. 6, lane 4). Alternatively, the repair enzyme may have different
reactivities with respect to the particular damage occurring in DNA. For
example, one of the bands in the overexposed lane was produced by cuts 7
bases to the 5' side of a run of 3 C's and thus could be due to incision
reactions in the complementary strand opposite runs of DDP crosslinked GG's.
Another site of incision was 7 bases to the 5' side of a run of pyrimidines
and may have been due to UV-induced damage although we attempted to minimize
UV exposure in the purification of DNA. Cutting was observed for a few AG
base sequences and may indicate that cis-DDP reacted with some of these
sites dependent upon their adjacent base sequence.
Recently, DNA treated with cis-DDP has been enzymatically digested and
the platinum adducts quantitated and in some cases characterized (29,30).
The major adduct observed by Fichtinger-Schepman et al. (30) was
cis-Pt(NH3)2d(pGpG) which accounted for about 60% of the total bound
platinum. Thus, it is not surprising that we were able to detect cutting by
the UVR nuclease at these adducts. A second major adduct occurring at about
1/3 the frequency of the intrastrand crosslink between guanines was
cis-Pt(NH3)2d(pApG). Possibly under our reaction conditions the frequency
of this adduct was too low to be detectable by the UVR nuclease reaction or
this adduct occurred at only a few of the AG sequences in the DNA. The
occurrence of an adduct at particular bases in DNA has been found to be
affected by the adjacent base sequence (14,31,32). This has been observed
with the inhibition of restriction enzyme reactions (31) and exonuclease III
digestion (14,32) at sites of platinum adducts. This may explain why we
failed to see a cutting band for one pair of adjacent GG's in the Bam HI -
Sal I fragment. Alternatively, the failure to find an incision band may be
due to the presence of a second platinum adduct in this G rich fragment
which could interfere with the incision reaction. Minor adducts such as
cross-linked guanines separated by a third base, Pt(NH3)3dGMP due to
monofunctional reaction of platinum compounds or cis-Pt(NH3)2d(GMP)2 due to
interstrand crosslinks of two guanines occur at low frequencies (30).
Incision reactions by the repair nuclease for such adducts would most likely
not be detected.
Additionally, these results indicate that adducts in supercoiled DNA
may be more sensitive to the incision reactions of the UVR nuclease than
adducts in linear DNA. Plasmid DNA with as few as 5 platinum adducts caused
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by treatment with either cis-DDP or trans-DDP was sensitive to the UVRABC
nuclease and the supercoiled form I molecules were converted to the relaxed
form by incision reactions of the repair nuclease. Since trans-DDP does not
cause intrastrand crosslinks between adjacent GG's, the UVRABC nuclease may
be acting on regions of local denaturation in DNA caused by different
platinum adducts. Evidence for such denatured regions are inherent in the
observation that both forms of the isomer caused plasmid DNA to become
hypersensitive to Si nuclease (33, unpublished observation of Popoff and
Beck). Production of topological distortions by platinum adducts would be
expected to have greater consequences in supercoiled DNA than in linear DNA.
Topological perturbation of DNA by DDP is indicated by the fact that
unwinding of supercoiled DNA results after its reaction with either drug
(34).
It is significant that even though both drugs form adducts in
supercoiled DNA which are sensitive to the UVRABC enzyme, only the
cis-compound is exceptionally lethal to uvr mutants. It may be the case
that only cis-DDP reacts with adjacent guanines in DNA to form intrastrand
crosslinks that must be removed from the DNA for cell survival by the repair
enzyme and that are detected in assays using end-labeled linear DNA. This
confirms the hypothesis of Stone et al. (12-13) that only cis-DDP causes
crosslinking of adjacent guanines. However, both drugs cause adducts which
are sensitive to the repair nuclease since supercoiled DNA treated with
either drug is cut by the nuclease. Further studies are necessary to reveal
the nature and significance of these adducts. These results suggest that
the topology of DNA may be an important factor in the UVRABC excision
nuclease reactivity.
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